Mankind Pharma Limited (NSE:MANKIND)
2,200.80
-60.40 (-2.67%)
At close: Jan 9, 2026
-23.57% (1Y)
| Market Cap | 908.50B |
| Revenue (ttm) | 135.46B |
| Net Income (ttm) | 17.51B |
| Shares Out | 412.81M |
| EPS (ttm) | 42.63 |
| PE Ratio | 51.70 |
| Forward PE | 39.32 |
| Dividend | 2.00 (0.09%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 396,485 |
| Average Volume | 423,594 |
| Open | 2,250.00 |
| Previous Close | 2,261.20 |
| Day's Range | 2,186.00 - 2,250.70 |
| 52-Week Range | 2,090.00 - 2,883.00 |
| Beta | 0.27 |
| RSI | 48.57 |
| Earnings Date | Feb 3, 2026 |